Top

Published in:

01-09-2015 | Co-infections and Comorbidity (S Naggie, Section Editor)

Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment

Authors: Emma Kaplan-Lewis, Daniel Seth Fierer

Published in: Current HIV/AIDS Reports | Issue 3/2015

Abstract

Hepatitis C virus (HCV) is not considered to be efficiently transmitted sexually, but since the early 2000s, HCV infection of HIV-infected men who have sex with men has emerged as an epidemic worldwide. In this review, we discuss the epidemiology of sexually transmitted acute HCV, the growing body of literature regarding risk factors for acquisition, and possible mechanisms of transmission. We also discuss the progression of liver disease in these men and the advances in therapy of acute HCV with interferon-free regimens and put forth our current approach of evaluating and treating these men in New York City.

Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497–505.PubMedCrossRef

Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr. 2005;40(1):41–6.PubMedCrossRef

Ghosn J, Pierre-François S, Thibault V, Duvivier C, Tubiana R, Simon A, et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 2004;5(4):303–6.PubMedCrossRef

Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001–2009. Euro Surveill. 2010;15(39):19673.PubMed

Van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136(5):1609–17.PubMedCentralPubMedCrossRef

Vogel M. Epidemiology and treatment of sexually transmitted acute hepatitis C. Curr Opin HIV AIDS. 2007;2(6):454–9.PubMed

Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2009;48(5):650–8.PubMedCentralPubMedCrossRef

Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41(1):31–6.PubMedCentralPubMedCrossRef

Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis. 2008;198(5):683–6.PubMedCentralPubMedCrossRef

10.

Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis. 2005;25(1):7–17.PubMedCrossRef

11.

Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion (Paris). 2005;45(6):994–1002.CrossRef

12.

Thomson EC, Nastouli E, Main J, Karayiannis P, Eliahoo J, Muir D, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS Lond Engl. 2009;23(1):89–93.CrossRef

13.••

Vanhommerig JW, Thomas XV, van der Meer JTM, Geskus RB, Bruisten SM, Molenkamp R. Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin Infect Dis. 2014;59(12):1678–85. Demonstrated median time to HCV antibody seroconversion of 74 days in HIV-infected MSM, somewhat longer than expected in HIV-uninfected men. This study was the first to demonstrate sero-reversion amongst a high proportion those cured by interferon treatment. PubMedCrossRef

14.

Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:3.

15.

Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10.PubMedCrossRef

16.

Fierer DS. Epidemic of sexually transmitted hepatitis C virus infection among HIV-infected men. Curr Infect Dis Rep. 2010;12(2):118–25.PubMedCrossRef

17.

Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, et al. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals—experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis. 2009;49(2):317–9. author reply 319.PubMedCrossRef

18.

Vanhommerig JW, van de Laar TJW, Koot M, van Rooijen MS, Schinkel J, Speksnijder AGCL, et al. Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV. J Virol Methods. 2015;213:147–50.PubMedCrossRef

19.

Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS Lond Engl. 2009;23(12):F1–7.CrossRef

20.

Wandeler G, Gsponer T, Bregenzer A, Günthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55(10):1408–16.PubMedCrossRef

21.

Sun H-Y, Chang S-Y, Yang Z-Y, Lu C-L, Wu H, Yeh C-C, et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012;50(3):781–7.PubMedCentralPubMedCrossRef

22.

Nishijima T, Shimbo T, Komatsu H, Hamada Y, Gatanaga H, Oka S. Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo. J Acquir Immune Defic Syndr. 2014;65(2):213–7.PubMedCrossRef

23.

Ishikani M, Watanabe K, Tsukada K, Nozaki Y, Yanase M, Igari T, et al. Acute hepatitis C in HIV-1 infected Japanese cohort: single center retrospective cohort study. PLoS One. 2014;9(6).

24.••

Urbanus AT, Van De Laar TJW, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995–2010. AIDS Lond Engl. 2014;28(5):781–90. Demonstrated an almost four-fold increase in HCV incidence among MSM in Amsterdam and described associated risk factors including fisting. CrossRef

25.•

Vanhommerig JW, Stolte IG, Lambers FAE, Geskus RB, van de Laar TJW, Bruisten SM, et al. Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr. 2014;66(5):e111–5. Showed a plateau in rates of HCV seroconversion among HIV-infected MSM beginning in about 2005 in the Amsterdam cohort, although calculations didn't account for reinfections of men who remained seropositive after cure. PubMedCrossRef

26.

Lambers FAE, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS Lond Engl. 2011;25(17):F21–7.CrossRef

27.•

Fierer DS, Dieterich DT, Mullen MP, Branch AD, Uriel AJ, Carriero DC, et al. Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis. 2014;58(6):873–9. The first study to use DAA in acute HCV, demonstrated SVR12 rates of 84% with just 12-week course telaprevir + peg-IFN + RBV, compared to 63% treated with peg-IFN + RBV for 24+ weeks. PubMedCentralPubMedCrossRef

28.•

Ingiliz P, Krznaric I, Stellbrink H-J, Knecht G, Lutz T, Noah C, et al. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med. 2014;15(6):355–61. The large experience from this cohort in Berlin provides sobering evidence of continued behaviors associated with reinfection even after interferon treatment. PubMedCrossRef

29.

Ristig MB, Tebas P, Gandy I, Qaqish R, Aberg JA. Cure of acute hepatitis C in HIV co-infection? J Clin Gastroenterol. 2004;38(3):303.PubMedCrossRef

30.

Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men—New York City, 2005–2010. MMWR Morb Mortal Wkly Rep. 2011;60(28):945–50.

31.

Garg S, Taylor LE, Grasso C, Mayer KH. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. Clin Infect Dis. 2013;56(10):1480–7.PubMedCentralPubMedCrossRef

32.•

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, et al. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic. AIDS Patient Care STDS. 2014;28(1):4–9. Showed the low rate of consistent screening for HCV among high-risk patients even at an academic medical center. PubMedCentralPubMedCrossRef

33.

Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis. 2011;52(6):812–8.PubMedCentralPubMedCrossRef

34.•

Witt MD, Seaberg EC, Darilay A, Young S, Badri S, Rinaldo CR, et al. Clin Infect Dis. 2013;57(1):77–84. A large cohort study in the US showing a stable incidence of HCV in MSM over 17 years, although not in the cities earliest/hardest hit in the epidemic. PubMedCentralPubMedCrossRef

35.••

Breskin A, Drobnik A, Pathela P, Chan C, Braunstein S, Bornschlegel K, et al. Factors associated with hepatitis C infection among HIV-infected men who have sex with men with no reported injection drug use in New York City, 2000–2010. In Press; First and very large population study of this epidemic, finding over 2,000 incident cases of HCV infection in HIV-infected MSM in NYC. Incident syphilis was significantly associated with subsequent HCV. Hispanics and blacks were disproportionately affected compared to whites.

36.

Fierer DS, Factor S. Defining the scope of sexually transmitted HCV epidemic among HIV-infeced men who have sex with men in NYC. Sex Transm Dis. In Press.

37.

Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS Lond Engl. 2007;21(8):983–91.CrossRef

38.

Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany—a case-control study. PLoS One. 2011;6(3):e17781.PubMedCentralPubMedCrossRef

39.•

Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, et al. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr. 2015;68(5):585–93. Case control study which demonstrated for the first time that douching is a risk for sexual transmission of HCV. PubMedCrossRef

40.

Luo L, Reilly KH, Xu JJ, Wang GX, Ding GW, Wang N, Wang HB. Prevalence and correlates of Trichomonas vaginalis infection among female sex workers in a city of Yunnan Province, China. Int J STD AIDS. 2015 May 7.

41.

Annang L, Grimley DM, Hook EW. Vaginal douche practices among black women at risk: exploring douching prevalence, reasons for douching, and sexually transmitted disease infection. Sex Transm Dis. 2006;33(4):215–9.PubMedCrossRef

42.

Blackwell CW. Serosorting sexual partners by gay and bisexual men to prevent HIV infection: implications for public health clinicians. Public Health Nurs Boston Mass. 2015 Feb 6.

43.•

Volk JE, Marcus JL, Phengrasamy T, Hare CB. Incident hepatitis C Virus infections among users of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015 Feb 18. Worrisome as the possible harbinger of the epidemic expanding into HIV-uninfected MSM, an unintended consequence to one of the most important advances in HIV prevention in the last decade.

44.

Leruez-Ville M, Kunstmann JM, De Almeida M, Rouzioux C, Chaix ML. Detection of hepatitis C virus in the semen of infected men. Lancet. 2000;356(9223):42–3.PubMedCrossRef

45.

Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS Lond Engl. 2000;14(14):2093–9.CrossRef

46.

Briat A, Dulioust E, Galimand J, Fontaine H, Chaix M-L, Letur-Könirsch H, et al. Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS Lond Engl. 2005;19(16):1827–35.CrossRef

47.••

Bradshaw D, Lamoury F, Catlett B, Applegate TL, Mcallister J, Dore GJ, et al. A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals. J Infect Dis. 2015;211(5):736–43. The first study to exam seminal HCV in men with acute/recent HCV infection. Seminal VL was actually lower during acute HCV, correlating with overall lower serum HCV during acute HCV in these men. PubMedCrossRef

48.•

Kouyos RD, Rauch A, Braun DL, Yang W-L, Böni J, Yerly S, et al. Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide. J Infect Dis. 2014;210(10):1555–61. An elegantly conceived study using molecular virological techniques developed to examine HIV transmission and extrapolating to HCV transmission. The results suggested that HIV-infected MSM who participated more vigorously in sex at the time they acquired HIV were more likely to subsequently become HCV infected than those who had not. PubMedCrossRef

49.

Cooper F, Barber T. “Gay bowel syndrome”: relic or real (and returning) phenomenon? Curr Opin Infect Dis. 2014;27(1):84–9.PubMedCrossRef

50.

Heiman KE, Karlsson M, Grass J, Howie B, Kirkcaldy RD, Mahon B, et al. Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men—United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2014;63(6):132–3.PubMed

51.

Morgan O, Crook P, Cheasty T, Jiggle B, Giraudon I, Hughes H, et al. Shigella sonnei outbreak among homosexual men. Emerg Infect Dis. 2006;12(9):1458–60.PubMedCentralPubMedCrossRef

52.

Di Benedetto MA, Di Piazza F, Amodio E, Taormina S, Romano N, Firenze A. Prevalence of sexually transmitted infections and enteric protozoa among homosexual men in western Sicily (south Italy). Prev Med Hyg. 2012;53(4):181–5.

53.

De Vries HJC, van der Bij AK, Fennema JSA, Smit C, de Wolf F, Prins M, et al. Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis. 2008;35(2):203–8.PubMedCrossRef

54.

Fierer DS, Mullen MP, Dieterich DT, Isabel Fiel M, Branch AD. Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis. 2012;55(6):887–8.PubMedCentralPubMedCrossRef

55.

Fierer DS, Dieterich DT, Fiel MI, Branch AD, Marks KM, Fusco DN, et al. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis. 2013;56(7):1038–43.PubMedCentralPubMedCrossRef

56.

Vogel M, Page E, Boesecke C, Reiberger T, Schwarze-Zander C, Mauss S, et al. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis. 2012;54(4):556–9.PubMedCrossRef

57.

Lambers FAE, Brinkman K, Schinkel J, Spijkerman IJB, Molenkamp R, Coutinho RA, et al. Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration. AIDS Lond Engl. 2011;25(10):1333–6.CrossRef

58.•

Franco S, Tural C, Nevot M, Moltó J, Rockstroh JK, Clotet B, et al. Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man. Gastroenterology. 2014;147(3):599–601. This report is the first evidence of what many of us were worried would happen, parallel to the situation in HIV infection, that treatment-induced resistance in HCV is of sufficient representation in the swarm of transmitting virus and is fit enough to be transmitted during sex. PubMedCrossRef

59.

European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2014. J Hepatol. 2014;61(2):373–95.CrossRef

60.

HCV guidelines management of acute HCV infection [Internet]. [cited 2015 Mar 29]. Available from: http://www.hcvguidelines.org/full-report/management-acute-hcv-infection.

61.

Deterding K, Grüner N, Buggisch P, Wiegand J, Galle PR, Spengler U, et al. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial. Lancet Infect Dis. 2013;13(6):497–506.PubMedCrossRef

62.

Kamal SM, Moustafa KN, Chen J, Fehr J, Abdel Moneim A, Khalifa KE, et al. Duration of peg interferon therapy in acute hepatitis C: a randomized trial. Hepatolog y. 2006;43(5):923–31.CrossRef

Title: Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment
Authors: Emma Kaplan-Lewis
Daniel Seth Fierer
Publication date: 01-09-2015
Publisher: Springer US
Published in: Current HIV/AIDS Reports / Issue 3/2015
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-015-0279-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Eosinophilia in Patients Infected with Human Immunodeficiency Virus

Emerging Challenges in Managing Hepatitis B in HIV Patients

The Role of Viral Co-Infection in HIV-Associated Non-AIDS-Related Cancers

Drug Interactions of Hepatitis C Direct-Acting Antivirals in the HIV-Infected Person

The Role of Statins in the Setting of HIV Infection

Treatment of Chronic HCV Genotype 1 Coinfection

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials